IKENA ONCOLOGY INC's ticker is IKNA and the CUSIP is 45175G108. A total of 55 filers reported holding IKENA ONCOLOGY INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $536 | +34.0% | 325,713 | +15.2% | 0.00% | +100.0% |
| Q1 2024 | $400 | +875.6% | 282,782 | +1201.8% | 0.00% | – |
| Q4 2023 | $41 | -6.8% | 21,722 | +113.0% | 0.00% | – |
| Q3 2023 | $44 | -38.9% | 10,198 | -10.4% | 0.00% | – |
| Q2 2023 | $72 | +60.0% | 11,388 | -14.4% | 0.00% | – |
| Q1 2023 | $45 | +32.4% | 13,301 | 0.0% | 0.00% | – |
| Q4 2022 | $34 | -99.9% | 13,301 | 0.0% | 0.00% | – |
| Q3 2022 | $45,000 | 0.0% | 13,301 | +30.4% | 0.00% | – |
| Q2 2022 | $45,000 | – | 10,198 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,249,123 | $3,711,053 | 2.75% |
| Blue Owl Capital Holdings LP | 4,091,118 | $6,750,345 | 1.88% |
| Atlas Venture Life Science Advisors, LLC | 5,018,178 | $8,279,994 | 0.87% |
| BML Capital Management, LLC | 585,114 | $965,438 | 0.69% |
| Acuitas Investments, LLC | 399,879 | $659,800 | 0.35% |
| Deuterium Capital Management, LLC | 80,578 | $132,954 | 0.22% |
| BVF INC/IL | 4,769,164 | $7,869,121 | 0.22% |
| Orbimed Advisors | 3,539,358 | $5,839,941 | 0.12% |
| NEA Management Company, LLC | 570,050 | $940,583 | 0.07% |
| Sofinnova Investments, Inc. | 382,616 | $631,316 | 0.03% |